Intranasal Interferon- 2, Treatment of Experimental Rhinoviral Colds
- 1 August 1984
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 150 (2), 174-180
- https://doi.org/10.1093/infdis/150.2.174
Abstract
The therapeutic efficacy of recombinant interferon-α2, (HuIFN-α2) in experimental infection with rhinovirus type 39 was assessed in two randomized, double-blind, placebo- controlled studies. Adult volunteers (serum neutralizing antibody titer, ⩽1:2) were given 9 × 106 international units of HuIFN-α2 three times a day for five days by intranasal spray (study 1) or drops (study 2) beginning 28 hr after rhinovirus inoculation. HuIFN-α2 did not prevent rhinovirus infection or colds in either study. Treatment by nasal drops and to a lesser extent by spray was associated with significant reductions in duration and quantity of viral shedding. Treatment by drops was associated with significant but modest effects on nasal symptom scores and trends toward reduced quantities of production of nasal mucus. Despite lower nasal wash concentrations of interferon, HuIFN-α2 drops appeared to have greater antiviral activity and therapeutic efficacy than did HuIFN-α2 spray. These findings suggest that HuIFN-α2 may not be therapeutically useful in treating naturally occurring rhinoviral colds.Keywords
This publication has 8 references indexed in Scilit:
- Human Tolerance and Histopathologic Effects of Long-Term Administration of Intranasal Interferon- 2The Journal of Infectious Diseases, 1983
- Intranasal Interferon 2 for Prevention of Rhinovirus Infection and IllnessThe Journal of Infectious Diseases, 1983
- Efficacy and Tolerance of Intranasally Applied Recombinant Leukocyte A Interferon in Normal VolunteersThe Journal of Infectious Diseases, 1983
- Anti-interferon antibody increases rhinovirus isolation rates from nasal wash specimens containing interferon-alpha2Antiviral Research, 1983
- Automated, quantitative cytopathic effect reduction assay for interferonJournal of Clinical Microbiology, 1982
- PREVENTION OF RHINOVIRUS COLDS BY HUMAN INTERFERON ALPHA-2 FROM ESCHERICHIA COLIThe Lancet, 1982
- Purified interferon as protection against rhinovirus infection.BMJ, 1982
- Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infectionAntimicrobial Agents and Chemotherapy, 1982